China SXT Pharmaceuticals (STU:2RY0) Beginning Cash Position : €10.55 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is China SXT Pharmaceuticals Beginning Cash Position?

China SXT Pharmaceuticals's Beginning Cash Position for the quarter that ended in Mar. 2024 was €10.55 Mil.

China SXT Pharmaceuticals's quarterly Beginning Cash Position increased from Mar. 2023 (€2.79 Mil) to Sep. 2023 (€16.27 Mil) but then declined from Sep. 2023 (€16.27 Mil) to Mar. 2024 (€10.55 Mil).

China SXT Pharmaceuticals's annual Beginning Cash Position increased from Mar. 2022 (€12.13 Mil) to Mar. 2023 (€14.54 Mil) and increased from Mar. 2023 (€14.54 Mil) to Mar. 2024 (€15.98 Mil).

China SXT Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for China SXT Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Beginning Cash Position Chart

China SXT Pharmaceuticals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Beginning Cash Position

Get a 7-Day Free Trial

8.41

6.12

12.13

14.54

15.98

China SXT Pharmaceuticals Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial										0.03	15.73	2.79	16.27	10.55

China SXT Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

China SXT Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

China SXT Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (STU:2RY0) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

SXTC:USA

Address

No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300

Website

http://www.sxtchina.com

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

China SXT Pharmaceuticals Headlines

No Headlines